SEARCH

SEARCH BY CITATION

References

  • 1
    Countdown Coverage Writing Group Countdown to 2015 Core Group, Bryce J, Daelmans B, Dwivedi A, Fauveau V, Lawn JE, Mason E, Newby H, Shankar A, Starrs A, Wardlaw T. Countdown to 2015 for maternal, newborn, and child survival: the 2008 report on tracking coverage of interventions. Lancet 2008;371:124758.
  • 2
    Koblinsky M, Matthews Z, Hussein J, Mavalankar D, Mridha MK, Anwar I, et al. Going to scale with professional skilled care. Lancet 2006;368:137786.
  • 3
    Campbell OM, Graham WJ; Lancet Maternal Survival Series steering group. Strategies for reducing maternal mortality: getting on with what works. Lancet 2006;368:128499.
  • 4
    Shankar A, Bartlett L, Fauveau V, Islam M, Terreri N; Countdown to 2015 Maternal Health Group. Delivery of MDG 5 by active management with data. Lancet 2008;371:12234.
  • 5
    Tsu VD. Highlighting the role of technologies in the battle against maternal mortality: introduction to a Bellagio workshop. Int J Gynaecol Obstet 2004;85(Suppl 1):S12.
  • 6
    Tsu VD. New and underutilized technologies to reduce maternal mortality: Papers from a 2003 Bellagio workshop. Int J Gynecol Obstet 2004;85(Suppl 1):S193.
  • 7
    Tsu VD. New and underused technologies to reduce maternal mortality. Lancet 2004;363:756.
  • 8
    Tsu VD, Shane B. New and underutilized technologies to reduce maternal mortality: call to action from a Bellagio workshop. Int J Gynaecol Obstet 2004;85(Suppl 1):S8393.
  • 9
    Akhter S, Begum MR, Kabir J. Condom hydrostatic tamponade for massive postpartum hemorrhage. Int J Gynaecol Obstet 2005;90:1345.
  • 10
    Doumouchtsis SK, Papageorghiou AT, Arulkumaran S. Systematic review of conservative management of postpartum hemorrhage: what to do when medical treatment fails. Obstet Gynecol Surv 2007;62:5407.
  • 11
    World Health Organization. Human reproduction programme revised budget 2008-2009. 2008;WHO/RHR/HRP/08.12:1722.
  • 12
    Abalos E, Duley L, Steyn DW, Henderson-Smart DJ. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 2007:CD002252.
  • 13
    Duley L, Henderson-Smart DJ, Meher S. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database Syst Rev 2006:CD001449.
  • 14
    Verkuyl DA Think globally act locally: the case for symphysiotomy. PLoS Med 2007;4:e71.
  • 15
    van Eygen L, Rutgers S. Caesarean section as preferred mode of delivery in term breech presentations is not a realistic option in rural Zimbabwe. Trop Doct 2008;38:369.
  • 16
    Fauveau V, de Bernis L. “Good obstetrics” revisited: too many evidence-based practices and devices are not used. Int J Gynaecol Obstet 2006;94:17984.
  • 17
    Sunday-Adeoye IM, Okonta P, Twomey D. Symphysiotomy at the Mater Misericordiae Hospital Afikpo, Ebonyi State of Nigeria (1982-1999): a review of 1013 cases. J Obstet Gynaecol 2004;24:5259.
  • 18
    West KP Jr, Katz J, Khatry SK, LeClerq SC, Pradhan EK, Shrestha SR. Double blind, cluster randomised trial of low dose supplementation with vitamin A or beta carotene on mortality related to pregnancy in Nepal. The NNIPS-2 Study Group. BMJ 1999;318:5705.
  • 19
    West KP Jr. Vitamin A deficiency as a preventable cause of maternal mortality in undernourished societies: plausibility and next steps. Int J Gynaecol Obstet 2004;85 (Suppl 1):S247.
  • 20
    Christian P, West KP Jr, Labrique A, Klemm R, Rashid M, Shamim AA, et al. Effects of maternal vitamin a or beta-carotene supplementation on maternal and infant mortality in rural Bangladesh: the JiVitA-1 trial. Consequences and control of micronutrient deficiencies: Science, Policy, and Programs—defining the issues. Presentation at the International Life Sciences Institute Micronutrient Forum, 16–18 April 2007; Istanbul, Turkey.
  • 21
    Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet 2006;367:106674.
  • 22
    AbouZahr C. Global burden of maternal death and disability. Br Med Bull 2003;67:111.
  • 23
    McDonald S. Management of the third stage of labor. J Midwifery Womens Health 2007;52:25461.
  • 24
    Armbruster D, Fullerton J. Cord clamping and active management of the third stage. J Midwifery Womens Health 2007;52:526.
  • 25
    Strand RT, Da Silva F, Jangsten E, Bergström S. Postpartum hemorrhage: a prospective, comparative study in Angola using a new disposable device for oxytocin administration. Acta Obstet Gynecol Scand 2005;84:2605.
  • 26
    Tsu VD, Mai TT, Nguyen YH, Luu HT. Reducing postpartum hemorrhage in Vietnam: assessing the effectiveness of active management of third-stage labor. J Obstet Gynaecol Res 2006;32:48996.
  • 27
    Tsu VD, Luu HT, Mai TT. Does a novel prefilled injection device make postpartum oxytocin easier to administer? Results from midwives in Vietnam. Midwifery 2008 (In press).
  • 28
    Høj L, Cardoso P, Nielsen BB, Hvidman L, Nielsen J, Aaby P. Effect of sublingual misoprostol on severe postpartum haemorrhage in a primary health centre in Guinea-Bissau: randomised double blind clinical trial. BMJ 2005;331:723.
  • 29
    Walraven G, Blum J, Dampha Y, Sowe M, Morison L, Winikoff B, et al. Misoprostol in the management of the third stage of labour in the home delivery setting in rural Gambia: a randomised controlled trial. BJOG 2005;112:127783.
  • 30
    Derman RJ, Kodkany BS, Goudar SS, Geller SE, Naik VA, Bellad MB, et al. Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: a randomised controlled trial. Lancet 2006;368:124853.
  • 31
    Enakpene CA, Morhason-Bello IO, Enakpene EO, Arowojolu AO, Omigbodun AO. Oral misoprostol for the prevention of primary post-partum hemorrhage during third stage of labor. J Obstet Gynaecol Res 2007;33:81017.
  • 32
    Alfirevic Z, Blum J, Walraven G, Weeks A, Winikoff B. Prevention of postpartum hemorrhage with misoprostol. Int J Gynaecol Obstet 2007;99 (Suppl 2):S198201.
  • 33
    Gülmezoglu AM, Forna F, Villar J, Hofmeyr GJ. Prostaglandins for preventing postpartum haemorrhage. Cochrane Database Syst Rev 2007:CD000494.
  • 34
    Venture Strategies for Health and Development website. Misoprostol for Maternal Health. [http://www.venturestrategies.org/projects/index.php?status=current&id=jloxq0_1l2ml8]. Accessed 18 July 2008.
  • 35
    Abdel-Aleem H, Hofmeyr GJ, Shokry M, El-Sonoosy E. Uterine massage and postpartum blood loss. Int J Gynaecol Obstet 2006;93:2389.
  • 36
    Miller S, Ojengbede A, Turan JM, Ojengbede O, Butrick E, Hensleigh P. Anti-shock garments for obstetric hemorrhage. Curr Womens Health Rev 2007;3:19.
  • 37
    Non-Pneumatic Anti-Shock Garment for Obstetrical Hemorrhage (Zambia and Zimbabwe) clinical trial web page on the United States Clinical Trials website. [www.clinicaltrials.gov/ct2/show/NCT00488462?cntry1=AF%3AZW&rank=12]. Accessed 15 July 2008.
  • 38
    Blum J, Alfirevic Z, Walraven G, Weeks A, Winikoff B. Treatment of postpartum hemorrhage with misoprostol. Int J Gynaecol Obstet 2007;99 (Suppl 2):S2025.
  • 39
    Langer A, Villar J, Tell K, Kim T, Kennedy S. Reducing eclampsia-related deaths—a call to action. Lancet 2008;371:7056.
  • 40
    World Health Organization (WHO) DoRHaR. Managing Complications in Pregnancy and Childbirth: A Guide for Midwives and Doctors. Geneva, Switzerland: WHO, 2000.
  • 41
    Adewole IF, Oladokun A, Okewole AI, Omigbodun AO, Afolabi A, Ekele B, et al. Magnesium sulphate for treatment of eclampsia: the Nigerian experience. Afr J Med Med Sci 2000;29:23941.
  • 42
    Noor S, Halimi M, Faiz NR, Gull F, Akbar N. Magnesium sulphate in the prophylaxis and treatment of eclampsia. J Ayub Med Coll Abbottabad 2004;16:504.
  • 43
    Shamsuddin L, Nahar K, Nasrin B, Nahar S, Tamanna S, Kabir RM, et al. Use of parenteral magnesium sulphate in eclampsia and severe pre-eclampsia cases in a rural set up of Bangladesh. Bangladesh Med Res Counc Bull 2005;31:7582.
  • 44
    Chaudhary P. Eclampsia: before and after magnesium sulphate. J Nepal Med Assoc 2005;44:1248.
  • 45
    Choudhary P. Eclampsia: a hospital based retrospective study. Kathmandu Univ Med J 2003;1:23741.
  • 46
    Altman D, Carroli G, Duley L, Farrell B, Moodley J, Neilson J, et al. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet 2002;359:187790.
  • 47
    SEA-ORCHID Study Group, Laopaiboon M, Lumbiganon P, McDonald SJ, Henderson-Smart DJ, Green S, et al. Use of evidence-based practices in pregnancy and childbirth: South East Asia optimising reproductive and child health in developing countries project. PLoS ONE 2008;3:e2646.
  • 48
    Lumbiganon P, Gülmezoglu AM, Piaggio G, Langer A, Grimshaw J. Magnesium sulfate is not used for pre-eclampsia and eclampsia in Mexico and Thailand as much as it should be. Bull World Health Organ 2007;85:7637.
  • 49
    Aaserud M, Lewin S, Innvaer S, Paulsen EJ, Dahlgren AT, Trommald M, et al. Translating research into policy and practice in developing countries: a case study of magnesium sulphate for pre-eclampsia. BMC Health Serv Res 2005;5:68.
  • 50
    Sevene E, Lewin S, Mariano A, Woelk G, Oxman AD, Matinhure S, et al. System and market failures: the unavailability of magnesium sulphate for the treatment of eclampsia and pre-eclampsia in Mozambique and Zimbabwe. BMJ 2005;331:7659.
  • 51
    Fantahun M. Magnesium sulphate: a neglected life saving drug in Ethiopia? Ethiop Med J 2007;45:405.
  • 52
    EngenderHealth. Balancing the scales: expanding treatment for pregnant women with life-threatening hypertensive conditions in developing countries. 2007 [www.engenderhealth.org/files/pubs/maternal-health/EngenderHealth-Eclampsia-Report.pdf]. Accessed 31 July 2008.
  • 53
    Shilva, Saha SC, Kalra J, Prasad R. Safety and efficacy of low-dose MgSO4 in the treatment of eclampsia. Int J Gynaecol Obstet 2007;97:1501.
  • 54
    Begum R, Begum A, Johanson R, Ali MN, Akhter S. A low dose (“Dhaka”) magnesium sulphate regime for eclampsia. Acta Obstet Gynecol Scand 2001;80:9981002.
  • 55
    Begum MR, Begum A, Quadir E. Loading dose versus standard regime of magnesium sulfate in the management of eclampsia: a randomized trial. J Obstet Gynaecol Res 2002;28:1549.
  • 56
    Gynuity pre-eclampsia web page. [http://gynuity.org/programs/pre-eclampsia/]. Accessed 15 July 2008.
  • 57
    Villar J, Abdel-Aleem H, Merialdi M, Mathai M, Ali MM, Zavaleta N, et al. World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women. Am J Obstet Gynecol 2006;194:63949.
  • 58
    Bhutta ZA, Ahmed T, Black RE, Cousens S, Dewey K, Giugliani E, et al. What works? Interventions for maternal and child undernutrition and survival. Lancet 2008;371:41740.
  • 59
    Hofmeyr GJ, Duley L, Atallah A. Dietary calcium supplementation for prevention of pre-eclampsia and related problems: a systematic review and commentary. BJOG 2007;114:93343.
  • 60
    Meads CA, Cnossen JS, Meher S, Juarez-Garcia A, ter Riet G, Duley L, et al. Methods of prediction and prevention of pre-eclampsia: systematic reviews of accuracy and effectiveness literature with economic modelling. Health Technol Assess 2008;12:1270.
  • 61
    Spinnato JA II, Freire S, Pinto E Silva JL, Cunha Rudge MV, Martins-Costa S, Koch MA, et al. Antioxidant therapy to prevent preeclampsia: a randomized controlled trial. Obstet Gynecol 2007;110:131118.
  • 62
    Rumbold A, Duley L, Crowther CA, Haslam RR. Antioxidants for preventing pre-eclampsia. Cochrane Database Syst Rev 2008:CD004227.
  • 63
    Duley L, Henderson-Smart DJ, Meher S, King JF. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 2007:CD004659.pub2.
  • 64
    Askie LM, Duley L, Henderson-Smart DJ, Stewart LA; PARIS Collaborative Group. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet 2007;369:17918.
  • 65
    Widmer M, Villar J, Benigni A, Conde-Agudelo A, Karumanchi SA, Lindheimer M. Mapping the theories of preeclampsia and the role of angiogenic factors: a systematic review. Obstet Gynecol 2007;109:16880.
  • 66
    Creanga AA, Genadry RR. Obstetric fistulas: a clinical review. Int J Gynaecol Obstet 2007;99 (Suppl 1):S406.
  • 67
    Harvey SA, Blandón YC, McCaw-Binns A, Sandino I, Urbina L, Rodríguez C, et al. Are skilled birth attendants really skilled? A measurement method, some disturbing results and a potential way forward. Bull World Health Organ 2007;85:78390.
  • 68
    Oladapo OT, Daniel OJ, Olatunji AO. Knowledge and use of the partograph among healthcare personnel at the peripheral maternity centres in Nigeria. J Obstet Gynaecol 2006;26:53841.
  • 69
    Delvaux T, Aké-Tano O, Gohou-Kouassi V, Bosso P, Collin S, Ronsmans C. Quality of normal delivery care in Cote d’Ivoire. Afr J Reprod Health 2007;11:2232.
  • 70
    Pettersson KO, Svensson ML, Christensson K. Evaluation of an adapted model of the World Health Organization partograph used by Angolan midwives in a peripheral delivery unit. Midwifery 2000;16:828.
  • 71
    Fahdhy M, Chongsuvivatwong V. Evaluation of World Health Organization partograph implementation by midwives for maternity home birth in Medan, Indonesia. Midwifery 2005;21:30110.
  • 72
    Mathews JE, Rajaratnam A, George A, Mathai M. Comparison of two World Health Organization partographs. Int J Gynaecol Obstet 2007;96:14750.
  • 73
    Lavender T, Alfirevic Z, Walkinshaw S. Effect of different partogram action lines on birth outcomes: a randomized controlled trial. Obstet Gynecol 2006;108:295302.
  • 74
    Rozenholc AT, Ako SN, Leke RJ, Boulvain M. The diagnostic accuracy of external pelvimetry and maternal height to predict dystocia in nulliparous women: a study in Cameroon. BJOG 2007;114:6305.
  • 75
    Chang X, Chedraui P, Ross MG, Hidalgo L, Peñafiel J. Vacuum assisted delivery in Ecuador for prolonged second stage of labor: maternal-neonatal outcome. J Matern Fetal Neonatal Med 2007;20:3814.
  • 76
    Baskett TF, Fanning CA, Young DC. A prospective observational study of 1000 vacuum assisted deliveries with the OmniCup Device. J Obstet Gynaecol Can 2008;30:57380.
  • 77
    Attilakos G, Sibanda T, Winter C, Johnson N, Draycott T. A randomised controlled trial of a new handheld vacuum extraction device. BJOG 2005;112:151015.
  • 78
    Groom KM, Jones BA, Miller N, Paterson-Brown S. A prospective randomised controlled trial of the Kiwi OmniCup versus conventional ventouse cups for vacuum-assisted vaginal delivery. BJOG 2006;113:1839.
  • 79
    Hofmeyr GJ, Mathai M, Shah A, Novikova N. Techniques for caesarean section. Cochrane Database Syst Rev 2008:CD004662.
  • 80
    Mathai M, Hofmeyr GJ. Abdominal surgical incisions for caesarean section. Cochrane Database Syst Rev 2007:CD004453.
  • 81
    Anorlu RI, Maholwana B, Hofmeyr GJ. Methods of delivering the placenta at caesarean section. Cochrane Database Syst Rev 2008:CD004737.
  • 82
    Jacobs-Jokhan D, Hofmeyr G. Extra-abdominal versus intra-abdominal repair of the uterine incision at caesarean section. Cochrane Database Syst Rev 2004:CD000085.
  • 83
    Dodd JM, Anderson ER, Gates S. Surgical techniques for uterine incision and uterine closure at the time of caesarean section. Cochrane Database Syst Rev 2008:CD004732.
  • 84
    Bujold E, Bujold C, Hamilton EF, Harel F, Gauthier RJ. The impact of a single-layer or double-layer closure on uterine rupture. Am J Obstet Gynecol 2002;186:132630.
  • 85
    Gyamfi C, Juhasz G, Gyamfi P, Blumenfeld Y, Stone JL. Single- versus double-layer uterine incision closure and uterine rupture. J Matern Fetal Neonatal Med 2006;19:63943.
  • 86
    Saleem S, Reza T, McClure EM, Pasha O, Moss N, Rouse DJ, et al. Chlorhexidine vaginal and neonatal wipes in home births in Pakistan: a randomized controlled trial. Obstet Gynecol 2007;110:97785.
  • 87
    Goldenberg RL, McClure EM, Saleem S, Rouse D, Vermund S. Use of vaginally administered chlorhexidine during labor to improve pregnancy outcomes. Obstet Gynecol 2006;107:113946.
  • 88
    McClure EM, Goldenberg RL, Brandes N, Darmstadt GL, Wright LL; CHX Working Group, et al. The use of chlorhexidine to reduce maternal and neonatal mortality and morbidity in low-resource settings. Int J Gynaecol Obstet 2007;97:8994.
  • 89
    Sickbert-Bennett EE, Weber DJ, Gergen-Teague MF, Sobsey MD, Samsa GP, Rutala WA. Comparative efficacy of hand hygiene agents in the reduction of bacteria and viruses. Am J Infect Control 2005;33:6777.
  • 90
    Beckmann MM, Garrett AJ. Antenatal perineal massage for reducing perineal trauma. Cochrane Database Syst Rev 2006:CD005123.
  • 91
    Corbett MR, Turner KL. Essential elements of postabortion care: origins, evolution and future directions. Int Fam Plan Perspect 2003;29:10611.
  • 92
    Moreno-Ruiz NL, Borgatta L, Yanow S, Kapp N, Wiebe ER, Winikoff B. Alternatives to mifepristone for early medical abortion. Int J Gynaecol Obstet 2007;96:21218.
  • 93
    Aldrich T, Winikoff B. Does methotrexate confer a significant advantage over misoprostol alone for early medical abortion? A retrospective analysis of 8678 abortions. BJOG 2007;114:55562.
  • 94
    Ho PC, Blumenthal PD, Gemzell-Danielsson K, Gómez Ponce de León R, Mittal S, Tang OS. Misoprostol for the termination of pregnancy with a live fetus at 13 to 26 weeks. Int J Gynaecol Obstet 2007;99 (Suppl 2):S17881.
  • 95
    van Bogaert LJ, Sedibe TM. Efficacy of a single misoprostol regimen in the first and second trimester termination of pregnancy. J Obstet Gynaecol 2007;27:51012.
  • 96
    Blum J, Winikoff B, Gemzell-Danielsson K, Ho PC, Schiavon R, Weeks A. Treatment of incomplete abortion and miscarriage with misoprostol. Int J Gynaecol Obstet 2007;99 (Suppl 2):S1869.
  • 97
    Ipas website. Product New: Ipas EasyGrip® Cannulae Now Available. 2003 [www.ipas.org/Library/News/News_Items/Product_News_Ipas_EasyGripr_Cannulae_Now_Availab.aspx]. Accessed 22 July 2008.
  • 98
    Ipas website. Ipas announces next generation of a life-saving reproductive-health technology. 2004 [http://www.ipas.org/Library/News/News_Items/Ipas_announces_next_generation_of_a_life_saving_reproductive_health_technology.aspx]. Accessed 22 July 2008.
  • 99
    Warriner IK, Meirik O, Hoffman M, Morroni C, Harries J, My Huong NT, et al. Rates of complication in first-trimester manual vacuum aspiration abortion done by doctors and mid-level providers in South Africa and Vietnam: a randomised controlled equivalence trial. Lancet 2006;368:196572.
  • 100
    Faundes A, Fiala C, Tang OS, Velasco A. Misoprostol for the termination of pregnancy up to 12 completed weeks of pregnancy. Int J Gynaecol Obstet 2007;99 (Suppl 2):S1727.
  • 101
    de Bernis L Obstetric fistula: guiding principles for clinical management and programme development, a new WHO guideline. Int J Gynaecol Obstet 2007;99 (Suppl 1):S11721.
  • 102
    Velez A, Ramsey K, Tell K. The campaign to end fistula: what have we learned? Findings of facility and community needs assessments. Int J Gynaecol Obstet 2007;99 (Suppl 1):S14350.
  • 103
    Wall LL, Arrowsmith SD, Briggs ND, Browning A, Lassey A. The obstetric vesicovaginal fistula in the developing world. Obstet Gynecol Surv 2005;60 (Suppl 1):S351.
  • 104
    Browning A. Lack of value of the Martius fibrofatty graft in obstetric fistula repair. Int J Gynaecol Obstet 2006;93:337.
  • 105
    Nardos R, Browning A, Member B. Duration of bladder catheterization after surgery for obstetric fistula. Int J Gynaecol Obstet 2008;103:302.
  • 106
    Palma P, Riccetto C, Reges R, Fraga R, Miyaoka R, Hermann V, et al. Arcus to arcus microsling: technique and preliminary results. Int Urogynecol J Pelvic Floor Dysfunct 2008;19:11336.
  • 107
    Pollack J, Davila G. Device therapy for stress incontinence. In: DavilaG, GhoniemG, WexnerS, editors. Pelvic Floor Dysfunction: A Multidisciplinary Approach. Cambridge, MA: Birkhäuser; 2005. pp. 10911.
  • 108
    Anders K, Bidmead J. Intravaginal and intraurethral devices. Women’s Health Medicine 2005;2:302.
  • 109
    Goh JT, Browning A. Use of urethral plugs for urinary incontinence following fistula repair. Aust N Z J Obstet Gynaecol 2005;45:2378.